35 related articles for article (PubMed ID: 17608714)
1. Identification and clinical implications of recurrent PAX5::MLLT3 fusion in lymphoid blastic phase chronic myeloid leukemia.
Wang L; Chen Y; Wang Q; Xiang M; Zeng Z; Zhang Z; Zhang F; Chen S; Xue M
Int J Lab Hematol; 2024 Jun; 46(3):571-574. PubMed ID: 38389449
[No Abstract] [Full Text] [Related]
2. An unusual translocation, t(1;11)(q21;q23), in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome.
Gutiérrez LG; Noriega MF; Laudicina A; Quatrin M; Bengió RM; Larripa I
Oncol Lett; 2017 May; 13(5):3159-3162. PubMed ID: 28521421
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.
Wang W; Tang G; Cortes JE; Liu H; Ai D; Yin CC; Li S; Khoury JD; Bueso-Ramos C; Medeiros LJ; Hu S
J Hematol Oncol; 2015 Apr; 8():32. PubMed ID: 25888368
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib.
Zámečníkova A
Hematol Rep; 2011 Aug; 3(2):e13. PubMed ID: 22184534
[No Abstract] [Full Text] [Related]
5. Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7).
Jarmuz M; Kroll R; Przybyłowicz-Chalecka A; Ratajczak B; Gniot M; Szyfter K; Komarnicki M
Cancer Genet Cytogenet; 2010 May; 199(1):45-7. PubMed ID: 20417868
[TBL] [Abstract][Full Text] [Related]
6. Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia.
Henzan H; Yoshimoto G; Okeda A; Nagasaki Y; Hirano G; Takase K; Tanimoto T; Miyamoto T; Fukuda T; Nagafuji K; Harada M
Ann Hematol; 2004 Dec; 83(12):784-8. PubMed ID: 15322764
[TBL] [Abstract][Full Text] [Related]
7. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.
Suzuki K; Sugawara T; Kowata S; Utsugizawa T; Ito S; Murai K; Ishida Y
Cancer Genet Cytogenet; 2004 Apr; 150(2):159-63. PubMed ID: 15066325
[TBL] [Abstract][Full Text] [Related]
8. Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia.
Otero L; Moellmann AC; Pombo-de-Oliveira MS; Ornellas MH; Pires V; Bouzas LF; Fernandez Tde S
Eur J Haematol; 2007 Aug; 79(2):179-81. PubMed ID: 17608714
[No Abstract] [Full Text] [Related]
9. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
Becher R; Kloke O
Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
[TBL] [Abstract][Full Text] [Related]
10. [Chromosome aberrations in chronic myeloid leukemia].
Haus O
Acta Haematol Pol; 1992; 23(2 Suppl 1):5-12. PubMed ID: 1488873
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
